CON EDISON TO REPORT 2nd QUARTER 2022 EARNINGS ON AUGUST 4

PR Newswire


NEW YORK
, July 6, 2022 /PRNewswire/ — Consolidated Edison, Inc. (Con Edison) (NYSE:ED) plans to report its 2nd quarter 2022 earnings on August 4, 2022 after the market closes.

Consolidated Edison, Inc. is one of the nation’s largest investor-owned energy-delivery companies, with approximately $14 billion in annual revenues and $64 billion in assets. The company provides a wide range of energy-related products and services to its customers through the following subsidiaries: Consolidated Edison Company of New York, Inc. (CECONY), a regulated utility providing electric service in New York City and New York’sWestchester County, gas service in Manhattan, the Bronx, parts of Queens and parts of Westchester, and steam service in Manhattan; Orange and Rockland Utilities, Inc. (O&R), a regulated utility serving customers in a 1,300-square-mile-area in southeastern New York State and northern New Jersey; Con Edison Clean Energy Businesses, Inc., the second-largest owners of solar electric projects in North America, which, through its subsidiaries develops, owns and operates renewable and sustainable energy infrastructure projects and provides energy-related products and services to wholesale and retail customers; and Con Edison Transmission, Inc., which falls primarily under the oversight of the Federal Energy Regulatory Commission and through its subsidiaries invests in electric transmission projects supporting its parent company’s effort to transition to clean, renewable energy. Con Edison Transmission manages, through joint ventures, both electric and gas assets while seeking to develop electric transmission projects that will bring clean, renewable electricity to customers, focusing on New York, New England, the Mid-Atlantic states and the Midwest.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/con-edison-to-report-2nd-quarter-2022-earnings-on-august-4-301581818.html

SOURCE Consolidated Edison, Inc.

Cboe Global Markets Reports Trading Volume for June 2022

PR Newswire


CHICAGO
, July 6, 2022 /PRNewswire/ — Cboe Global Markets, Inc. (Cboe: CBOE), a leading provider of global market infrastructure and tradable products, today reported June monthly trading volume statistics across its global business lines and provided guidance for selected revenue per contract/net revenue capture metrics for the second quarter of 2022.

The data sheet “Cboe Global Markets Monthly Volume & RPC/Net Revenue Capture Report” contains an overview of certain June trading statistics and market share by business segment, volume in select index products, and RPC/net capture, which is reported on a one-month lag, across business lines.



Average Daily Trading Volume by Month



Year-To-Date



June
2022




June
2021




%



Chg



May



2022



%
Chg




June



2022



June



2021



%
Chg


Multiply-listed options (contracts, k)

10,255

10,232

0.2 %

10,691

-4.1 %

10,678

10,004

6.7 %

Index options (contracts, k)

2,842

1,778

59.9 %

2,853

-0.4 %

2,545

1,869

36.2 %

Futures (contracts, k)

201

182

10.3 %

248

-19.0 %

238

235

1.2 %

U.S. Equities – On-Exchange (matched shares, mn)

1,634

1,500

9.0 %

1,851

-11.7 %

1,774

1,848

-4.0 %

U.S. Equities – Off-Exchange (matched shares, mn)

83

76

10.1 %

104

-19.7 %

101

87

15.0 %

Canadian Equities1 (matched shares, k)

33,799

41,751

-19.0 %

38,013

-11.1 %

38,550

59,285

-35.0 %

European Equities (€, mn)

10,226

7,014

45.8 %

11,187

-8.6 %

11,863

7,405

60.2 %

EuroCCP Cleared Trades (k)

116,357

95,209

22.2 %

128,981

-9.8 %

810,789

593,025

36.7 %

EuroCCP Net Settlements (k)

839

824

1.9 %

892

-5.9 %

5,304

4,791

10.7 %

Australian Equities2 (AUD, mn)

877

N/A

836

4.9 %

863

N/A

Japanese Equities2 (JPY, bn)

147

N/A

111

32.1 %

149

N/A

Global FX ($, mn)

40,521

33,646

20.4 %

40,457

0.2 %

40,769

34,739

17.4 %



1
 Canadian Equities does not include NEO.



2
 Australian Equities and Japanese Equities data reflects Cboe’s acquisition of Cboe Asia Pacific (formerly Chi-X Asia Pacific) effective on July 1, 2021.



ADV= Average Daily Volume



ADNV= Average Daily Notional Value



NM=Not Meaningful 

June and Second-Quarter 2022 Trading Volume Highlights

U.S. Options

  • S&P 500 Index (SPX) options set a new monthly ADV record of 2.3 million contracts, surpassing the previous record of 2.2 million in May 2022. Total volume for the month reached nearly 48 million contracts.
  • SPX Weeklys Tuesday- and Thursday-expiring options continued their strong debut, with approximately 5.1 million Tuesdays options and 4.4 million Thursdays options traded in June.
  • Cboe opened its new trading floor in Chicago on June 6.

European Equities and Derivatives

  • Cboe Europe Equities had an overall market share of 23.5 percent in June, the highest month since August 2018.
  • Cboe BIDS Europe, Cboe’s European block trading platform, had a 33 percent share of the LIS (large-in-scale) market, making it the largest platform of its type (Source: big xyt).
  • Cboe Europe Derivatives (CEDX) traded 1,872 contracts during June, up from 1,475 during May.

Second-Quarter 2022 RPC/Net Revenue Capture Guidance

The projected RPC/net capture metrics for the second quarter of 2022 are estimated, preliminary and may change. There can be no assurance that our final RPC for the three months ended June 30, 2022, will not differ materially from these projections.



(In USD unless stated otherwise)



Two-Months
Ended




Three-Months Ended



Product:



2Q Projection



May-22



May-22



Apr-22



Mar-22



Feb-22

Multiply-Listed Options (per contract)


0.066

0.067

0.067

0.066

0.067

0.066

Index Options


0.884

0.880

0.870

0.863

0.857

0.850

Total Options


0.234

0.229

0.221

0.211

0.210

0.210

Futures (per contract)


1.697

1.675

1.675

1.667

1.637

1.625

U.S. Equities – Exchange (per 100 touched shares)


0.020

0.017

0.018

0.018

0.017

0.019

U.S. Equities – Off-Exchange (per 100 touched shares)


0.108

0.110

0.116

0.117

0.117

0.111

Canadian Equities (per 10,000 touched shares)



CAD 9.38

CAD 9.31

CAD 9.40

CAD 9.32

CAD 9.10

CAD 8.85

European Equities (per matched notional value)


0.235

0.234

0.229

0.229

0.230

0.238

Australian Equities (per matched notional value)


0.171

0.171

0.172

0.172

0.173

0.171

Japanese Equities (per matched notional value)


0.258

0.249

0.244

0.242

0.228

0.257

Global FX (per one million dollars traded)


2.705

2.713

2.696

2.685

2.674

2.723

EuroCCP Fee per Trade Cleared


€ 0.009

€ 0.009

€ 0.009

€ 0.009

€ 0.009

€ 0.010

EuroCCP Net Fee per Settlement


€ 0.796

€ 0.779

€ 0.809

€ 0.858

€ 0.924

€ 0.901

The above represents average revenue per contract (RPC) or net capture based on a three-month rolling average. For Options and Futures, the average RPC represents total net transaction fees recognized for the period divided by total contracts traded during the period for options exchanges: BZX Options, Cboe Options, C2 Options and EDGX Options; futures include contracts traded on Cboe Futures Exchange, LLC (CFE). For U.S. Equities – On-Exchange, “net capture per 100 touched shares” refers to transaction fees less liquidity payments and routing and clearing costs divided by the product of one-hundredth ADV of touched shares on BZX, BYX, EDGX and EDGA and the number of trading days for the period. For U.S. Equities – Off-Exchange, “net capture per 100 touched shares” refers to transaction fees less OMS/EMS costs and clearing costs divided by the product of one-hundredth ADV of touched shares on BIDS Trading and the number of trading days for the period. For Canadian Equities, “net capture per 10,000 touched shares” refers to transaction fees divided by the product of one-ten thousandth ADV of shares for MATCHNow and the number of trading days for the period (does not include NEO). For European Equities, “net capture per matched notional value” refers to transaction fees less liquidity payments in British pounds divided by the product of ADNV in British pounds of shares matched on Cboe Europe Equities and the number of trading days. For EuroCCP, “Fee per Trade Cleared” refers to clearing fees divided by number of non-interoperable trades cleared and “Net Fee per Settlement” refers to settlement fees less direct costs incurred to settle divided by the number of settlements executed after netting. For Australian Equities, “net capture per matched notional value” refers to transaction fees less liquidity payments in Australian Dollars divided by the product of ADNV in Australian Dollars of shares matched on Chi-X Australia and the number of trading days. For Japanese Equities, “net capture per matched notional value” refers to transaction fees less liquidity payments in Japanese Yen divided by the product of ADNV in Japanese Yen of shares matched on Chi-X Japan and the number of trading days. For Global FX, “net capture per one million dollars traded” refers to transaction fees less liquidity payments, if any, divided by the Spot and SEF products of one-thousandth of ADNV traded on the Cboe FX markets and the number of trading days, divided by two, which represents the buyer and seller that are both charged on the transaction. Average transaction fees per contract can be affected by various factors, including exchange fee rates, volume-based discounts and transaction mix by contract type and product type.

About Cboe Global Markets, Inc.

Cboe Global Markets (Cboe: CBOE), a leading provider of market infrastructure and tradable products, delivers cutting-edge trading, clearing and investment solutions to market participants around the world. The company is committed to operating a trusted, inclusive global marketplace, providing leading products, technology and data solutions that enable participants to define a sustainable financial future. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, FX and digital assets, across North America, Europe and Asia Pacific. To learn more, visit www.cboe.com.



Media Contacts



     Analyst Contact



Angela Tu



Tim Cave



Kenneth Hill, CFA

+1-646-856-8734

+44 (0) 7593-506-719

+1-312-786-7559


[email protected]


[email protected]


[email protected]

CBOE-V

Cboe®, Cboe Global Markets®, Cboe Volatility Index®
,
and VIX® are registered trademarks and
Cboe Futures ExchangeSM is a service mark
of Cboe Exchange, Inc. or its affiliates. Standard & Poor’s®, S&P®, SPX®, and S&P 500®  are registered trademarks of Standard & Poor’s Financial Services, LLC, and have been licensed for use by Cboe Exchange, Inc.
 All other trademarks and service marks are the property of their respective owners.

Any products that have the S&P Index or Indexes as their underlying interest are not sponsored, endorsed, sold or promoted by Standard & Poor’s or Cboe and neither Standard & Poor’s nor Cboe make any representations or recommendations concerning the advisability of investing in products that have S&P indexes as their underlying interests.
All other trademarks and service marks are the property of their respective owners.

Cboe Global Markets, Inc. and its affiliates do not recommend or make any representation as to possible benefits from any securities, futures or investments, or third-party products or services. Cboe Global Markets, Inc. is not affiliated with S&P. Investors should undertake their own due diligence regarding their securities, futures, and investment practices. This press release speaks only as of this date. Cboe Global Markets, Inc. disclaims any duty to update the information herein.

Nothing in this announcement should be considered a solicitation to buy or an offer to sell any securities or futures in any jurisdiction where the offer or solicitation would be unlawful under the laws of such jurisdiction. Nothing contained in this communication constitutes tax, legal or investment advice.  Investors must consult their tax adviser or legal counsel for advice and information concerning their particular situation.

Cboe Global Markets, Inc.  and  its  affiliates make  no  warranty,  expressed  or  implied,  including,  without  limitation,  any  warranties  as  of  merchantability,  fitness  for  a particular  purpose,  accuracy,  completeness  or  timeliness,  the  results to  be  obtained  by  recipients  of  the  products  and  services  described  herein, or as to the ability of the indices referenced in this press release to track the performance of their respective securities, generally, or the performance of the indices referenced in this press release or any subset of their respective securities, and shall not in any way be liable for any inaccuracies, errors. Cboe Global Markets, Inc. and its affiliates have not calculated, composed or determined the constituents or weightings of the securities that comprise the third-party indices referenced in this press release and shall not in any way be liable for any inaccuracies or errors in any of the indices referenced in this press release.

Options involve risk and are not suitable for all market participants. Prior to buying or selling an option, a person should review the  Characteristics and Risks of Standardized Options (ODD), which is required to be provided to all such persons.  Copies of the ODD are available from your broker or from The Options Clearing Corporation, 125 S. Franklin Street, Suite 1200, Chicago, IL 60606. 

Futures trading is not suitable for all investors and involves the risk of loss. That risk of loss can be substantial and can exceed the amount of money deposited for a futures position. You should, therefore, carefully consider whether futures trading is suitable for you in light of your circumstances and financial resources. You should put at risk only funds that you can afford to lose without affecting your lifestyle. For additional information regarding futures trading risks, see the Risk Disclosure Statement set forth in Appendix A to CFTC Regulation 1.55(c) and the Risk Disclosure Statement for Security Futures Contracts.

Cautionary Statements Regarding Forward-Looking Information

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. You can identify these statements by forward-looking words such as “may,” “might,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” and the negative of these terms and other comparable terminology. All statements that reflect our expectations, assumptions or projections about the future other than statements of historical fact are forward-looking statements. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from those expressed or implied by the forward-looking statements.

We operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Some factors that could cause actual results to differ include: the loss of our right to exclusively list and trade certain index options and futures products; economic, political and market conditions; compliance with legal and regulatory obligations; price competition and consolidation in our industry; decreases in trading or clearing volumes, market data fees or a shift in the mix of products traded on our exchanges; legislative or regulatory changes or changes in tax regimes; our ability to protect our systems and communication networks from security risks, cybersecurity risks, insider threats and unauthorized disclosure of confidential information; our ability to attract and retain skilled management and other personnel; increasing competition by foreign and domestic entities; our dependence on and exposure to risk from third parties; fluctuations to currency exchange rates; factors that impact the quality and integrity of our indices; the impact of the novel coronavirus (“COVID-19”) pandemic; our ability to operate our business without violating the intellectual property rights of others and the costs associated with protecting our intellectual property rights; our ability to minimize the risks, including our credit and default risks, associated with operating a European clearinghouse; our ability to accommodate trading and clearing volume and transaction traffic, including significant increases, without failure or degradation of performance of our systems; misconduct by those who use our markets or our products or for whom we clear transactions; challenges to our use of open source software code; our ability to meet our compliance obligations, including managing potential conflicts between our regulatory responsibilities and our for-profit status; our ability to maintain BIDS Trading as an independently managed and operated trading venue, separate from and not integrated with our registered national securities exchanges; damage to our reputation; the ability of our compliance and risk management methods to effectively monitor and manage our risks; our ability to manage our growth and strategic acquisitions or alliances effectively; restrictions imposed by our debt obligations and our ability to make payments on or refinance our debt obligations; our ability to maintain an investment grade credit rating; impairment of our goodwill, long-lived assets, investments or intangible assets; the accuracy of our estimates and expectations; litigation risks and other liabilities; and operating a digital asset business. More detailed information about factors that may affect our actual results to differ may be found in our filings with the SEC, including in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings made from time to time with the SEC.

We do not undertake, and we expressly disclaim, any duty to update any forward-looking statement whether as a result of new information, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cboe-global-markets-reports-trading-volume-for-june-2022-301581796.html

SOURCE Cboe Global Markets, Inc.

Delek Logistics Partners, LP to Host Second Quarter 2022 Conference Call on August 4th

PR Newswire


BRENTWOOD, Tenn.
, July 6, 2022 /PRNewswire/ — Delek Logistics Partners, LP (NYSE: DKL) (“Delek Logistics”) today announced that the Partnership intends to issue a press release summarizing second quarter 2022 results before the U.S. stock market opens on Thursday, August 4, 2022. A conference call to discuss these results is scheduled to begin at 9:00 a.m. CT (10:00 a.m. ET) on Thursday, August 4, 2022.

The live broadcast of this conference call will be available online by going to www.DelekLogistics.com and clicking on the webcasts section of the website. The online replay will be available on the website for 90 days.

Investors may also wish to listen to Delek US Holdings, Inc.’s (NYSE: DK) (“Delek US”) second quarter 2022 earnings conference call on Thursday, August 4, 2022 at 10:00 a.m. CT (11:00 a.m. ET) and review Delek US’ earnings press release. Market trends and information disclosed by Delek US may be relevant to Delek Logistics, as it is a consolidated subsidiary of Delek US. Investors can find information related to Delek US and the timing of its earnings release online by going to www.DelekUS.com.

About Delek Logistics Partners, LP

Delek Logistics Partners, LP is a midstream energy master limited partnership headquartered in Brentwood, Tennessee. Through its owned assets and joint ventures located primarily in and around the Permian Basin, the Delaware Basin and other select areas in the Gulf Coast region and giving effect to the 3Bear acquisition, Delek Logistics Partners, LP provides gathering, pipeline and other transportation services primarily for crude oil and natural gas customers, storage, wholesale marketing and terminalling services primarily for intermediate and refined product customers, and water disposal and recycling services. Delek US Holdings, Inc. (NYSE: DK) (“Delek US”) owns the general partner interest as well as a majority limited partner interest in Delek Logistics Partners, LP, and is also a significant customer.

Information about Delek Logistics Partners, LP can be found on its website (www.deleklogistics.com), investor relations webpage (https://www.deleklogistics.com/investor-relations), news webpage (https://www.deleklogistics.com/news-releases) and its Twitter account (@DelekLogistics).

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/delek-logistics-partners-lp-to-host-second-quarter-2022-conference-call-on-august-4th-301581755.html

SOURCE Delek Logistics

Federal Realty Investment Trust Announces Second Quarter 2022 Earnings Release Date and Conference Call Information

PR Newswire

N. BETHESDA, Md., July 6, 2022 /PRNewswire/ — Federal Realty Investment Trust (NYSE: FRT) will announce second quarter 2022 earnings in a press release to be issued before market open on Thursday, August 4, 2022. The Company will host a conference call on Thursday, August 4th, at 11:00 AM ET

Event: Federal Realty Investment Trust’s Second Quarter 2022 Earnings Conference Call

When: 11:00 AM ET, Thursday, August 4, 2022

Live Webcast:
FRT Second Quarter 2022 Earnings Conference Call or www.federalrealty.com

Dial #: 877.407.9208; Passcode: 13729950

A replay of the webcast will be available 30 minutes after the conclusion of the call on Federal Realty’s website at www.federalrealty.com. A telephonic replay of the conference call will also be available through August 18, 2022 by dialing 844.512.2921; Passcode: 13729950.

About Federal Realty

Federal Realty is a recognized leader in the ownership, operation and redevelopment of high-quality retail-based properties located primarily in major coastal markets from Washington, D.C. to Boston as well as San Francisco and Los Angeles. Founded in 1962, Federal Realty’s mission is to deliver long-term, sustainable growth through investing in communities where retail demand exceeds supply. Its expertise includes creating urban, mixed-use neighborhoods like Santana Row in San Jose, California, Pike & Rose in North Bethesda, Maryland and Assembly Row in Somerville, Massachusetts. These unique and vibrant environments that combine shopping, dining, living and working provide a destination experience valued by their respective communities. Federal Realty’s 104 properties include approximately 3,100 tenants, in 25 million square feet, and approximately 3,400 residential units. 

Federal Realty has increased its quarterly dividends to its shareholders for 54 consecutive years, the longest record in the REIT industry. Federal Realty is an S&P 500 index member and its shares are traded on the NYSE under the symbol FRT. For additional information about Federal Realty and its properties, visit www.federalrealty.com.

Investor Inquiries:

Leah Andress Brady

Vice President, Investor Relations

301.998.8265


[email protected]

Media Inquiries:

Brenda Pomar

Director, Corporate Communications

301.998.8316


[email protected]

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/federal-realty-investment-trust-announces-second-quarter-2022-earnings-release-date-and-conference-call-information-301581585.html

SOURCE Federal Realty Investment Trust

Delek US Holdings to Host Second Quarter 2022 Conference Call on August 4th

PR Newswire


BRENTWOOD, Tenn.
, July 6, 2022 /PRNewswire/ — Delek US Holdings, Inc. (NYSE: DK) (“Delek US”) today announced that the Company intends to issue a press release summarizing second quarter 2022 results before the U.S. stock market opens on Thursday, August 4, 2022. A conference call to discuss these results is scheduled to begin at 10:00 a.m. CT (11:00 a.m. ET) on Thursday, August 4, 2022.

The live broadcast of this conference call will be available online by going to www.DelekUS.com and clicking on the investor relations section of the website.  The online replay will be available on the website for 90 days.

Investors may also wish to listen to Delek Logistics Partners, LP’s (NYSE: DKL) (“Delek Logistics”) second quarter 2022 earnings conference call on Thursday, August 4, 2022 at 9:00 a.m. CT (10:00 a.m. ET) and review Delek Logistics’ earnings press release. Market trends and information disclosed by Delek Logistics may be relevant to the logistics segment reported by Delek US. Investors can find information related to Delek Logistics and the timing of its earnings release online by going to www.DelekLogistics.com.

About Delek US Holdings, Inc.

Delek US Holdings, Inc. is a diversified downstream energy company with assets in petroleum refining, logistics, asphalt, renewable fuels and convenience store retailing.  The refining assets consist of refineries operated in Tyler and Big Spring, Texas, El Dorado, Arkansas and Krotz Springs, Louisiana with a combined nameplate crude throughput capacity of 302,000 barrels per day.

The logistics operations consist of Delek Logistics. Delek US and its affiliates also own the general partner and an approximate 80 percent limited partner interest in Delek Logistics. Delek Logistics is a growth-oriented master limited partnership focused on owning and operating midstream energy infrastructure assets.

The convenience store retail business operates approximately 250 convenience stores in central and west Texas and New Mexico.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/delek-us-holdings-to-host-second-quarter-2022-conference-call-on-august-4th-301581757.html

SOURCE Delek US Holdings, Inc.

First Citizens BancShares, Inc. Announces Date of 2022 Second Quarter Earnings Call

RALEIGH, N.C., July 06, 2022 (GLOBE NEWSWIRE) — First Citizens BancShares, Inc. today announced that it will report its financial results for the second quarter ended June 30, 2022, before the U.S. financial markets open on Thursday, July 28, 2022.

In addition, First Citizens will host a conference call to discuss the company’s financial results on July 28, 2022, at 9 a.m. Eastern time.

To access this call, dial:
   
United States: 1-844-200-6205
Canada: 1-833-950-0062
All other locations:  +1-929-526-1599
Access Code: 158564

The earnings presentation and news release will be available on the company’s website at www.firstcitizens.com/investor-relations.

After the conference call, you may access a replay of the call through August 18, 2022, by dialing 1-866-813-9403 (United States), 1-226-828-7578 (Canada) or +44-204-525-0658 (all other locations) with access code 908758.

About First Citizens BancShares

First Citizens BancShares, Inc. is the financial holding company for First Citizens Bank. In January 2022, First Citizens BancShares and CIT Group Inc. merged – creating one of the top 20 U.S. financial institutions, with more than $100 billion in assets.

First Citizens Bank helps personal, business, commercial and wealth clients build financial strength that lasts. As the largest family-controlled bank in the United States, First Citizens is continuing a unique legacy of strength, stability and long-term thinking that has spanned generations. Its commercial banking segment brings a wide array of best-in-class lending, leasing and banking services to middle-market companies and small businesses from coast to coast. Founded in 1898 and headquartered in Raleigh, N.C., First Citizens also operates a nationwide direct bank and a network of more than 550 branches in 22 states, many in high-growth markets. Visit firstcitizens.com. First Citizens Bank. Forever First®

Contact: Deanna Hart
Investor Relations
919-716-2137
Frank Smith
Corporate Communications
919-716-4121



Altisource Asset Management Corporation Announces Appointment of CEO

CHRISTIANSTED, U.S. Virgin Islands, July 06, 2022 (GLOBE NEWSWIRE) — Altisource Asset Management Corporation (“AAMC” or the “Company”) (NYSE American: AAMC) today announced that the Board of Directors (the “Board”) has appointed Jason Kopcak as the Chief Executive Officer of the Company and as a member of the Board. Prior to his appointment, Mr. Kopcak had been the President and Chief Operating Officer of the Company. The Board also appointed current director John P. de Jongh, Jr. as Chairman of the Board. Mr. de Jongh, Jr. had previously been interim Chairman of the Board.

“The Board is pleased to announce the appointment of Jason as Chief Executive Officer and as a member of the Board. Jason’s vision of a new AAMC has impressed the Board and we look forward to he and the senior management team continuing to build out our new alternative lending business and assess other opportunities,” said John P. de Jongh, Jr., Chairman of the Board of AAMC.

“I appreciate the Board’s confidence in appointing me Chief Executive Officer and a member of the Board. I look forward to working with the Board even more closely in the future as we develop the Company’s alternative lending platform. The Board and I are excited about the new businesses for AAMC and believe we are in a strong position to succeed in these areas and provide value to our shareholders,” said Jason Kopcak, Chief Executive Officer.

About AAMC

AAMC is an alternative lending company that provides liquidity and capital to under-served markets. We also continue to assess opportunities that could potentially be of long-term benefit to shareholders such as our Crypto-ATMs.   Additional information is available at www.altisourceamc.com.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding management’s beliefs, estimates, projections, anticipations, and assumptions. These statements may be identified by words such as “anticipate,” “intend,” “expect,” “may,” “could,” “should,” “would,” “plan,” “estimate,” “target,” “seek,” “believe” and other expressions or words of similar meaning. We caution that forward-looking statements are qualified by the existence of certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements.

The statements made in this press release are current as of the date of this press release only. The Company undertakes no obligation to publicly update or revise any forward-looking statements or any other information contained herein, whether as a result of new information, future events or otherwise.



FOR FURTHER INFORMATION CONTACT:
Investor Relations
T: +1-704-275-9113
E: [email protected]

Assure Holdings Announces Partnership with Hayden IR

DENVER, July 06, 2022 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services has retained Hayden IR, LLC to broaden Assure’s awareness within the investor and financial community and support the Company’s investor relations program.

John A. Farlinger, Assure’s executive chairman and CEO, said, “We engaged Hayden IR to help us expand our outreach and exposure to the investment community as well as assist with communicating our progress as we continue to grow our business.”

Brett Maas, Managing Partner at Hayden IR, said, “We are excited to introduce Assure to our extensive network of investment professionals. We look forward to working with Assure as they continue to build a telehealth remote neurology services business with exceptional capabilities in IONM and numerous adjacent markets.”

About Assure Holdings

Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.

Forward-Looking Statements

This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to comments with respect to: the performance of Hayden IR in assisting the Company with communicating progress of the Company’s business and expectations with respect to the Company’s growth and development and the quality and results of future services. Forward-looking statements may generally be identified by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” “target,” or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and business, its remote neurology business, and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 14, 2022, and available on the Company’s EDGAR profile at www.sec.gov, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

Contact

Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
(720) 617-2526
[email protected]



Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, Ireland and CHICAGO, July 06, 2022 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that it has granted a non-statutory share option to purchase an aggregate of 10,000 ordinary shares of the Company as an inducement to a newly hired employee. This grant was awarded pursuant to the Nasdaq inducement grant exception as a component of new hire employment compensation.

The share option was granted effective July 5, 2022 with an exercise price of $0.22 per share, which is equal to the closing price of Iterum Therapeutics’ ordinary shares on the date of grant. The share option has a 10-year term and vests on August 30, 2023, subject to the employee’s continued service with the Company through the vesting date. The share option was approved by the Company’s Compensation Committee and was granted as an inducement material to the new employee’s acceptance of employment in accordance with Nasdaq Listing Rule 5635(c)(4). The share option is subject to the terms and conditions of a share option agreement covering the grant and the Company’s 2021 Inducement Equity Incentive Plan.

About Iterum Therapeutics plc

Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum Therapeutics is advancing its first compound, sulopenem, a novel penem anti-infective compound, in Phase 3 clinical development with an oral formulation and IV formulation. Sulopenem has demonstrated potent in vitro activity against a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. Iterum Therapeutics has received Qualified Infectious Disease Product (QIDP) and Fast Track designations for its oral and IV formulations of sulopenem in seven indications.

Investor Contact:

Judy Matthews 
Chief Financial Officer
312-778-6073
[email protected]



Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

DEERFIELD, Ill., July 06, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has granted restricted stock unit awards to one (1) employee, who was not an executive officer, as an inducement for them to accept employment with Surgalign, and representing the right to receive, in the aggregate, up to 9,259 shares of Surgalign common stock. The award was granted on July 1, 2022 and it was made under the Surgalign Holdings, Inc. 2021 Inducement Plan. One-third of the restricted stock units vest on the first anniversary of the date of grant, and one-eighth of the remaining restricted stock units vest on each subsequent quarterly anniversary of the date of grant, such that the award will be fully vested on the third anniversary of the date of grant, subject to continued employment through the applicable vesting date.

The awards were approved by the independent Compensation Committee of the Board of Directors of Surgalign Holdings and were granted to the new employees as an inducement material to their acceptance of employment with Surgalign pursuant to Nasdaq rules.

About Surgalign Holdings, Inc.

Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health and is building out its digital surgery platform to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies surgeons will look to for what is truly possible for their patients. Surgalign is focused on bringing surgeons solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.

Forward Looking Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign’s website at www.surgalign.com or the SEC’s website at www.sec.gov.

Investor and Media Contact:

Glenn Wiener
[email protected]
+1 917 887 8434